相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore
Yuta Tanaka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
Shengxiang Ren et al.
JOURNAL OF THORACIC ONCOLOGY (2022)
Design, synthesis and biological evaluation of antitumor platinum(II) agents conjugated with non-steroidal anti-inflammatory drug species
Ju Zang et al.
BIOORGANIC CHEMISTRY (2022)
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit
Nicky J. Willis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Two Scalable Syntheses of 3-(Trifluoromethyl)cyclobutane-1-carboxylic Acid
Zhiguo J. Song et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2021)
Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response
Zuojie Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Platinum(IV) antitumor complexes and their nano-drug delivery
Chunyan Jia et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Novel CK2-Specific Pt(II) Compound Reverses Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments
Yuanjiang Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
Philipp Fronik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting drug delivery system for platinum(IV)-Based antitumor complexes
Yunshuang Zhong et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives
Chunqiu Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A trifunctional Pt(II) complex alleviates the NHEJ/HR-related DSBs repairs to evade cisplatin-resistance in NSCLC
Xing Wang et al.
BIOORGANIC CHEMISTRY (2020)
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer
Maurizio Sabbatini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Juan-Miguel Cejalvo et al.
ESMO OPEN (2019)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Non-coordination planer cis-and trans-configuration of cis-[Pt(II)(mixed-NH3/RNH2)(3-OH-cyclobutane-1,1-dicarboxylate)]: separation, characterization, and anticancer activity
Jing Jiang et al.
RESEARCH ON CHEMICAL INTERMEDIATES (2018)
A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research
Dorian M. Cheff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Study on Antitumor Platinum(II) Complexes of Chiral Diamines with Dicyclic Species as Steric Hindrance
Fengfan Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Applications of Fluorine in Medicinal Chemistry
Eric P. Gillis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Potent Anticancer Activity and Possible Low Toxicity of Platinum(II) Complexes with Functionalized 1,1-Cyclobutanedicarboxylate as a Leaving Ligand
Jian Zhao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane derivatives as carrier ligands and 3-hydroxycyclobutane-1,1-dicarboxylate as a leaving group: Potent cytotoxicity and DNA binding ability
Lei Fang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
In Vitro Anticancer Activity of cis-Diammineplatinum(II) Complexes with β-Diketonate Leaving Group Ligands
Justin J. Wilson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
3-Hydroxycarboplatin, a Simple Carboplatin Derivative Endowed with an Improved Toxicological Profile
Weiping Liu et al.
PLATINUM METALS REVIEW (2012)
Platinum-based antitumor drugs containing enantiomerically pure α-trifluoromethyl alanine as ligand
N Margiotta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Carboplatin derivatives with superior antitumor activity compared to the parent compound
G Bernhardt et al.
INORGANICA CHIMICA ACTA (2004)